Allogeneic stem cell transplantation for patients age ≥ 70 years with myelodysplastic syndrome: a retrospective study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT
Abstract: In this retrospective analysis we evaluated the outcome of 313 patients aged ≥ 70 years in the registry of the European Group for Blood and Marrow Transplantation with myelodysplastic syndrome (MDS; n = 221) and secondary acute myeloid leukemia (n = 92) who underwent allogeneic hematopoietic stem cell transplantation (HSCT) from related (n = 79) or unrelated (n = 234) donors. Median age at HSCT was 72 years (range, 70 to 78). Conditioning regimen was nonmyeloablative (n = 54), reduced intensity (n = 207), or standard intensity (n = 52). Allogeneic HSCT for MDS patients ≥ 70 years was increasingly performed over time. Although during 2000 to 2004 only 16 patients received HSCT, during 2011 to 2013 the number of transplantations increased to 181. The cumulative incidence of nonrelapse mortality at 1 year and relapse at 3 years was 32% and 28%, respectively, with a 3-year overall survival rate of 34%. Good performance, determined by Karnofsky performance status, and recipients' seronegativity for cytomegalovirus was associated with 3-year estimated overall survival rates of 43% (P = .01) and 46% (P = .002), respectively. Conditioning intensity did not impact survival. After careful patient selection, allogeneic HSCT can be offered to patients older than 70 years with MDS
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Biology of blood and marrow transplantation. - 23, 1 (2017) , 44-52, ISSN: 1523-6536
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2021
- Urheber
- DOI
-
10.1016/j.bbmt.2016.09.027
- URN
-
urn:nbn:de:bsz:25-freidok-1749659
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Heidenreich, Silke
- Finke, Jürgen
- Kröger, Nicolaus
- Universität
Entstanden
- 2021
Ähnliche Objekte (12)
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT
Proof of the GM-MDS conjecture
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC)
Bacterial Viruses Subcommittee and Archaeal Viruses Subcommittee of the ICTV: update of taxonomy changes in 2021
On the lower bound of cost of MDS matrices
Child Emigration: Report of the R.C.I. Sub-Committee.
Half a century of healing: celebrating the 50th anniversary of EBMT
The Procedures of the Parity Commission and of its Sub-Committee on Wages
The value of serum IL-4 to predict the survival of MDS patients
Targeting the Immunomodulatory Capacity of MDS MSCs by Tasquinimod
P771: Prognostic characteristics of patients with MDS with aberrations of chromosome 5. Data from the Düsseldorf MDS registry
Imaging and Interpretation of Axial Spondylarthritis: The Radiologist's Perspective—Consensus of the Arthritis Subcommittee of the ESSR
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT
Proof of the GM-MDS conjecture
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC)
Bacterial Viruses Subcommittee and Archaeal Viruses Subcommittee of the ICTV: update of taxonomy changes in 2021
On the lower bound of cost of MDS matrices
Child Emigration: Report of the R.C.I. Sub-Committee.
Half a century of healing: celebrating the 50th anniversary of EBMT
The Procedures of the Parity Commission and of its Sub-Committee on Wages
The value of serum IL-4 to predict the survival of MDS patients
Targeting the Immunomodulatory Capacity of MDS MSCs by Tasquinimod
P771: Prognostic characteristics of patients with MDS with aberrations of chromosome 5. Data from the Düsseldorf MDS registry
Imaging and Interpretation of Axial Spondylarthritis: The Radiologist's Perspective—Consensus of the Arthritis Subcommittee of the ESSR
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT
Proof of the GM-MDS conjecture
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC)
Bacterial Viruses Subcommittee and Archaeal Viruses Subcommittee of the ICTV: update of taxonomy changes in 2021
On the lower bound of cost of MDS matrices
Child Emigration: Report of the R.C.I. Sub-Committee.
Half a century of healing: celebrating the 50th anniversary of EBMT
The Procedures of the Parity Commission and of its Sub-Committee on Wages
The value of serum IL-4 to predict the survival of MDS patients
Targeting the Immunomodulatory Capacity of MDS MSCs by Tasquinimod
P771: Prognostic characteristics of patients with MDS with aberrations of chromosome 5. Data from the Düsseldorf MDS registry